• Mashup Score: 3

    Already listened on another platform? 0.25 AMA PRA Category 1 Credits ™, 0.25 ABIM MOC or 0.25 AANP, including 0.25 AANP Pharm The following relevant financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute. Mridu Gulati, MD, MPH: Speaker for Boehringer Ingelheim. Advisor for CDC/NIOSH. Researcher for Boehringer Ingelheim and Bristol Myers Squibb. George A. Mensah, MD: No relevant financial relationships disclosed. Charles Vega, MD, FAAFP (Moderator):

    Tweet Tweets with this article
    • .#NHLBI curriculum. #PrimaryCare: Earn CME credit via @PriMedCME podcast presented with @StopSarcoidosis on what to know about #sarcoidosis in the #lungs. #ImpSci @NIH. Speakers: Dr. George Mensah at @NIH_NHLBI & Dr. Mridu Gulati at @YaleMed. Listen here: https://t.co/BA63h3IpbS https://t.co/yzJcy9mqTp

  • Mashup Score: 0

    Lung cancer screening (LCS) decreases lung cancer related mortality among high-risk people who smoke cigarettes and has been endorsed by the US Preventive Services Task Force (USPSTF) since 2013 [1]. However, adoption of LCS has been limited with an estimated 5.7 % of the eligible population having been screened in the U.S. as of 2020 [2]. Even with this low uptake, racial and ethnic disparities…

    Tweet Tweets with this article
    • #Interventions to improve #lungcancer #screening among racially and ethnically minoritized groups: A scoping review #lungs https://t.co/C8t5KtY2Dk https://t.co/4FqjyM07o9